 | Amgen (NASDAQ:AMGN) Issues FY 2022 Earnings Guidance
marketbeat.com - August 18 at 7:02 AM |
| TheStreet Upgrades Amgen (NASDAQ:AMGN) to "B"
marketbeat.com - August 17 at 7:25 AM |
| Two Appealing Biotech Stocks for Two Distinct investors (AMGN)
marketbeat.com - August 8 at 11:11 AM |
| Should You Buy AbbVie Ahead Of Earnings? (AMGN)
marketbeat.com - July 28 at 8:40 AM |
 | Amgen (AMGN) is a Top-Ranked Value Stock: Should You Buy?
nasdaq.com - August 18 at 1:57 PM |
| AMGEN Inc. Shares Close in on 52-Week High - Market Mover - Nasdaq
nasdaq.com - August 17 at 6:16 AM |
| Amgen (AMGN) is a Top-Ranked Value Stock: Should You Buy? - Nasdaq
nasdaq.com - August 17 at 1:16 AM |
 | 5 Biotech Stocks in the Buy Zone This Week
stocknews.com - August 16 at 3:09 PM |
 | Amgen Moves to Dismiss Regeneron's Antitrust Case Regarding Cholesterol Drug
finance.yahoo.com - August 16 at 11:32 AM |
| Dogs of the Dow: 2 Stocks to Buy and 2 to Hold
stocknews.com - August 15 at 5:43 PM |
 | Amgen Inc. (AMGN) to Issue Quarterly Dividend of $1.94 on September 8th
americanbankingnews.com - August 15 at 7:20 AM |
|
 | Amgen deepens its roots in Tampa Bay - Tampa Bay Business Journal - The Business Journals
bizjournals.com - August 15 at 6:34 AM |
| Only Three Days Left To Cash In On Amgen's (NASDAQ:AMGN) Dividend
finance.yahoo.com - August 13 at 11:50 AM |
| The Zacks Analyst Blog Highlights Amgen, ChemoCentryx, Mersana Therapeutics, GSK and Vertex Pharmaceuticals - Nasdaq
nasdaq.com - August 12 at 9:01 AM |
| Amgen (NASDAQ:AMGN) Stock Rating Reaffirmed by Oppenheimer
americanbankingnews.com - August 12 at 5:14 AM |
 | Amgen under fire from Sen. Wyden over tax practices - Reuters (NASDAQ:AMGN) - Seeking Alpha
seekingalpha.com - August 11 at 6:00 PM |
 | Senate Finance Committee looks at Amgen taxes, widening drugmaker probe - Reuters
reuters.com - August 11 at 6:00 PM |
| Amgen (NASDAQ:AMGN) Rating Lowered to Buy at StockNews.com
americanbankingnews.com - August 10 at 2:36 AM |
| Amgen data for new cancer agent shows liver toxicity with immunotherapies
seekingalpha.com - August 9 at 10:24 AM |
| Equities Analysts Offer Predictions for Amgen Inc.'s FY2023 Earnings (NASDAQ:AMGN)
americanbankingnews.com - August 9 at 3:56 AM |
| MRTX stock gains as Amgen posts new combination data for rival cancer drug (NASDAQ:MRTX) - Seeking Alpha
seekingalpha.com - August 8 at 2:52 PM |
| Amgen's Lumakras/Keytruda/Tecentriq Combo Data Flags Safety Concern
finance.yahoo.com - August 8 at 2:52 PM |
| AMGEN PRESENTS NEW TARLATAMAB CLINICAL DATA AT WCLC 2022
finance.yahoo.com - August 8 at 2:52 PM |
| Amgen (NASDAQ:AMGN) Given New $236.00 Price Target at Royal Bank of Canada
americanbankingnews.com - August 8 at 4:36 AM |
| Amgen data for new cancer agent shows liver toxicity with immunotherapies (NASDAQ:AMGN) - Seeking Alpha
seekingalpha.com - August 7 at 10:50 PM |
| Amgen Stock: Adding To The Pipeline (NASDAQ:AMGN) - Seeking Alpha
seekingalpha.com - August 7 at 9:15 AM |
| Amgen says Lumakras plus immunotherapy for lung cancer needs further study - Reuters
reuters.com - August 7 at 7:48 AM |
 | Analyst Ratings for Amgen
markets.businessinsider.com - August 7 at 4:15 AM |
| Amgen (AMGN) Beats Q2 Earnings Estimates, to Buy Chemocentryx
finance.yahoo.com - August 7 at 4:15 AM |
 | Analyst Ratings for Amgen - Benzinga
benzinga.com - August 6 at 8:13 AM |
 | Siga Stock, Skyline, Amgen, Clearfield Among Best Stocks To Buy And Watch - Investor's Business Daily
investors.com - August 5 at 9:13 PM |
| What Are Whales Doing With Amgen - Benzinga
benzinga.com - August 5 at 2:58 AM |
 | Amgen Earnings Beat Estimates, Propelled by Top Drugs - Bloomberg
bloomberg.com - August 4 at 4:57 PM |
|
| Why ChemoCentryx Stock Is On Fire Today
finance.yahoo.com - August 4 at 10:29 AM |
| Amgen Q2 22 Earnings Conference Call At 5:00 PM ET - Nasdaq
nasdaq.com - August 4 at 8:25 AM |
| AMGEN TO ACQUIRE CHEMOCENTRYX FOR $4 BILLION IN CASH
finance.yahoo.com - August 4 at 8:25 AM |
| AMGEN ANNOUNCES 2022 THIRD QUARTER DIVIDEND
finance.yahoo.com - August 3 at 7:27 PM |
| AMGEN APPOINTS MICHAEL V. DRAKE TO BOARD OF DIRECTORS
finance.yahoo.com - August 3 at 7:27 PM |
 | $964 Billion Worldwide Biotechnology Industry to 2027 - Featuring Amgen, Biogen, Novartis and Pfizer Among Others - ResearchAndMarkets.com - Business Wire
businesswire.com - August 3 at 9:26 AM |
| AMGEN TO WEBCAST INVESTOR MEETING AT WCLC 2022
finance.yahoo.com - August 2 at 6:24 PM |
| Amgen disputes tax allegations, BP raises dividend after strong quarter, CA declares monkeypox emergency - Yahoo Finance
finance.yahoo.com - August 2 at 1:24 PM |
| Amgen (AMGN) to Release Earnings on Thursday
americanbankingnews.com - August 2 at 1:46 AM |
| AMGEN ANNOUNCES WEBCAST OF 2022 SECOND QUARTER FINANCIAL RESULTS - Yahoo Finance
finance.yahoo.com - August 2 at 12:12 AM |
| Amgen disputes IRS over $10.7B tax bill - WSJ
seekingalpha.com - August 1 at 7:11 PM |
| Amgen (AMGN) to Report Q2 Earnings: What's in the Cards?
finance.yahoo.com - August 1 at 7:11 PM |
| AMGEN ANNOUNCES WEBCAST OF 2022 SECOND QUARTER FINANCIAL RESULTS
finance.yahoo.com - August 1 at 7:10 PM |
| Amgen disputes IRS over $10.7B tax bill - WSJ (NASDAQ:AMGN) - Seeking Alpha
seekingalpha.com - August 1 at 2:10 PM |
| Amgen (AMGN) to Report Q2 Earnings: What's in the Cards? - Nasdaq
nasdaq.com - August 1 at 2:10 PM |
| Benzinga Before The Bell: Alibaba's Delisting Concerns, Amgen's Potential $10.7B Tax Bill, Kenya Will Not - Benzinga
benzinga.com - August 1 at 10:42 AM |
| Amgen To Fight IRS Agency Over Tax Bill Of Whooping $10.7B: Report - Benzinga
benzinga.com - August 1 at 8:07 AM |
 | Amgen Fights IRS Over $10.7 Billion Tax Bill - The Wall Street Journal
wsj.com - August 1 at 8:07 AM |
| Amgen Reaches Analyst Target Price
nasdaq.com - July 28 at 1:37 PM |
| $1000 Invested In Amgen 15 Years Ago Would Be Worth This Much Today - Benzinga - Benzinga
benzinga.com - July 27 at 7:19 PM |
| IDYA stock on watch as IDEAYA forms trial deal with Amgen for cancer agent (NASDAQ:IDYA) - Seeking Alpha
seekingalpha.com - July 27 at 2:18 PM |
